14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $14.00 $25.40 Wednesday, 1st May 2024 DCPH stock ended at $25.36. This is 0.356% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 0.514% from a day low at $25.27 to a day high of $25.40.
90 days $13.86 $25.40
52 weeks $9.90 $25.40

Historical Deciphera Pharmaceuticals Inc prices

Date Open High Low Close Volume
Mar 26, 2024 $15.46 $15.50 $14.79 $14.82 280 999
Mar 25, 2024 $15.34 $15.61 $15.25 $15.30 296 946
Mar 22, 2024 $15.55 $15.63 $15.23 $15.23 236 670
Mar 21, 2024 $15.82 $16.09 $15.48 $15.50 310 908
Mar 20, 2024 $15.00 $15.84 $15.00 $15.75 492 082
Mar 19, 2024 $14.92 $15.48 $14.86 $14.97 713 159
Mar 18, 2024 $15.55 $15.72 $14.65 $14.85 594 348
Mar 15, 2024 $15.83 $16.49 $15.55 $15.59 1 326 788
Mar 14, 2024 $15.80 $16.15 $15.57 $15.91 505 870
Mar 13, 2024 $16.30 $16.42 $15.78 $15.98 441 511
Mar 12, 2024 $16.49 $16.60 $16.09 $16.09 404 420
Mar 11, 2024 $17.07 $17.30 $16.43 $16.54 410 660
Mar 08, 2024 $17.06 $17.27 $16.68 $16.94 231 235
Mar 07, 2024 $17.05 $17.14 $16.78 $16.93 382 793
Mar 06, 2024 $16.92 $17.07 $16.74 $16.93 303 633
Mar 05, 2024 $16.63 $16.84 $16.47 $16.80 303 536
Mar 04, 2024 $17.42 $17.42 $16.33 $16.61 463 037
Mar 01, 2024 $16.81 $17.73 $16.74 $17.36 811 075
Feb 29, 2024 $17.12 $17.18 $16.65 $16.69 475 585
Feb 28, 2024 $16.86 $17.20 $16.80 $16.81 533 017
Feb 27, 2024 $16.55 $16.94 $16.13 $16.91 565 192
Feb 26, 2024 $16.01 $16.55 $16.01 $16.44 350 574
Feb 23, 2024 $15.82 $16.21 $15.81 $16.06 271 114
Feb 22, 2024 $15.49 $15.87 $15.42 $15.75 369 849
Feb 21, 2024 $15.38 $15.57 $15.12 $15.40 495 383
Click to get the best stock tips daily for free!

About Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. Th... DCPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT